Author/Creator: Whatling, Carl - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Whatling, Carl

1. Association of genetic variations with NAFLD in lean individuals. (12th October 2021)

Authors:: Lin, Huapeng; Wong, Grace L.‐H.; Whatling, Carl; Chan, Anthony W.‐H.; Leung, Howard H.‐W.; Tse, Chi‐Hang; Shu, Sally S.‐T.; Chim, Angel M.‐L.; Lai, Jimmy C.‐T.; Yip, Terry C.‐F.; Wong, Vincent W.‐S.
Journal:: Liver international
Issue:: Volume 42:Number 1(2022)
Page Start:: 149
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. ChemInform Abstract: Recent Advances for FLAP Inhibitors. Issue 30 (July 2015)

Authors:: Pettersen, Daniel; Davidsson, Oejvind; Whatling, Carl
Journal:: ChemInform
Issue:: Volume 46:Issue 30(2015)
Page Start:: no
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction. Issue 3 (2nd May 2021)

Authors:: Nelander, Karin; Lagerstrom‐Fermer, Maria; Amilon, Carl; Michaëlsson, Erik; Heijer, Maria; Kjaer, Magnus; Russell, Muir; Han, David; Lindstedt, Eva‐Lotte; Whatling, Carl; Gan, Li‐Ming; Ericsson, Hans
Journal:: Clinical and translational science
Issue:: Volume 14:Issue 3(2021)
Page Start:: 812
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Recent advances for FLAP inhibitors. Issue 13 (1st July 2015)

Authors:: Pettersen, Daniel; Davidsson, Öjvind; Whatling, Carl
Journal:: Bioorganic & medicinal chemistry letters
Issue:: Volume 25:Issue 13(2015)
Page Start:: 2607
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo‐controlled, phase I study in healthy volunteers. Issue 4 (18th February 2019)

Authors:: Gan, Li‐Ming; Lagerström‐Fermér, Maria; Ericsson, Hans; Nelander, Karin; Lindstedt, Eva‐Lotte; Michaëlsson, Erik; Kjaer, Magnus; Heijer, Maria; Whatling, Carl; Fuhr, Rainard
Journal:: British journal of clinical pharmacology
Issue:: Volume 85:Issue 4(2019)
Page Start:: 762
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo via an adenosine‐dependent mechanism. Issue 11 (10th August 2016)

Authors:: Mediero, Aránzazu; Wilder, Tuere; Reddy, Vishnu S. R.; Cheng, Qian; Tovar, Nick; Coelho, Paulo G.; Witek, Lukasz; Whatling, Carl; Cronstein, Bruce N.
Journal:: FASEB journal
Issue:: Volume 30:Issue 11(2016)
Page Start:: 3887
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗